Pneumococcal Vaccine UptakePROPELNCT06234683
PRomoting Older Adults' Pneumococcal Vaccination Through Education and Learning
A study testing Web-based educational video on pneumococcal vaccination and Reminder email to be vaccinated in people with Pneumococcal Vaccine Uptake and Vaccination Willingness, run by University of Ottawa at 1 site in Canada.
Trial summary
The goal of this trial is to compare the effect of a web-based educational video about pneumococcal vaccines and a reminder email to get vaccinated (intervention) with a reminder email alone (comparator) in adults aged 65 or older living in any Canadian province who reported not having received a pneumococcal vaccine. Read more about this study
- Who is it for?
- Ages 65 years and olderHealthy volunteers can take part
- Conditions the study is for
- Pneumococcal Vaccine Uptake, Vaccination Willingness, Pneumococcal Vaccine Knowledge
- What is being tested?
- Web-based educational video on pneumococcal vaccination and Reminder email to be vaccinated
- Type of treatment
- Vaccines
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 720 participants
- Where
- 1 siteCanada
- Study dates
- 6 Mar 2024to 12 Dec 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- Healthy volunteers accepted
- Older adult
Who may be able to join
- adults aged ≥ 65 residing in any Canadian province,
- community dwelling (i.e., living outside of nursing homes),
- reporting not having received a pneumococcal vaccine, and
- being able to understand English and/or French.
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Assessing Barriers to Pneumococcal Vaccination to Increase Vaccine Uptake Among Older Adults: a Web-based Educational Intervention
The goal of this trial is to compare the effect of a web-based educational video about pneumococcal vaccines and a reminder email to get vaccinated (intervention) with a reminder email alone (comparator) in adults aged 65 or older living in any Canadian province who reported not having received a pneumococcal vaccine.
The main questions this trial aims to answer are:
Read more
- does the educational intervention improve pneumococcal vaccine uptake,
- does the educational intervention improve willingness to be vaccinated,
- does the educational intervention improve knowledge of pneumococcal vaccination,
- and does the educational intervention improve attitudes towards pneumococcal vaccines/vaccination?
Eligible participants who provide electronic consent will:
- fill out a web-based baseline survey,
- receive access to the educational video (if assigned to the intervention group),
- receive an email reminder to be vaccinated (both groups),
- and fill in a web-based follow-up survey.
Read the detailed description
This research project is a web-based randomized controlled trial (RCT), targeting adults aged 65 years and older across all Canadian provinces. The primary objectives of this study are twofold. Firstly, it aims to assess the participants' knowledge, barriers, facilitators, and willingness to receive the pneumococcal vaccine at baseline. Secondly, it aims to evaluate the impact of a video-led educational intervention on pneumococcal vaccine literacy, willingness to be vaccinated, and the actual uptake of the vaccine. To this end, participants will be recruited through various online channels. Only individuals who have not received the pneumococcal vaccine will be considered eligible for inclusion. For the second objective, participants will be randomly assigned to either the intervention group (short video on pneumococcal vaccination) or the control group (reminder to receive a pneumococcal vaccine). Consenting participants will be required to complete two surveys: one at baseline and another approximately six months post-intervention. These surveys will provide valuable data for analyzing the effectiveness of the educational intervention in improving participants' knowledge, willingness to be vaccinated, and the actual uptake of the pneumococcal vaccine. Findings from this research will contribute to the understanding of factors influencing pneumococcal vaccine decision-making among older adults, ultimately informing strategies to enhance vaccine uptake and public health outcomes in this population.
- Conditions
- Pneumococcal Vaccine Uptake, Vaccination Willingness, Pneumococcal Vaccine Knowledge, Pneumococcal Vaccine Attitude
- Being tested
- Web-based educational video on pneumococcal vaccination, Reminder email to be vaccinated
- Keywords
- pneumococcal vaccines, older adults, vaccine hesitancy, health education, web-based intervention
- Medical subject headings
- Vaccination Hesitancy, Health Education
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Web-based educational video on pneumococcal vaccinationOther
Participants will receive a link to view a short video on pneumococcal vaccination.
Reminder email to be vaccinatedOther
Participants will receive a reminder email to be vaccinated.
| Study group | Role | What they receive |
|---|---|---|
| Web-based educational video on pneumococcal vaccination and reminder email to be vaccinated | Active comparator | Not described Receives: Other: Web-based educational video on pneumococcal vaccination; Other: Reminder email to be vaccinated |
| Reminder email to be vaccinated | Placebo comparator | Not described Receives: Other: Reminder email to be vaccinated |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pneumococcal vaccine uptake measured using a web-based follow-up survey four to six months post-randomization
Participants will be asked at follow-up whether they received a pneumococcal vaccine since the last survey (yes/no/do not know).
Measured: 4-6 months
Secondary outcomes (3)
Change in pneumococcal vaccination willingness, measured using web-based surveys (one at baseline and one four to six months post-randomization)
Participants will be asked at baseline and follow-up whether they would be willing to receive a pneumococcal vaccine (yes/no/do not know).
Measured: 4-6 months
Change in pneumococcal vaccine knowledge measured using web-based surveys (one at baseline and one four to six months post-randomization)
Participants will be asked about their vaccine knowledge at baseline and follow-up (yes/no/do not know).
Measured: 4-6 months
Change in pneumococcal vaccine attitudes measured using web-based surveys (one at baseline and one four to six months post-randomization)
Participants will be asked about their vaccine attitudes using Likert-type questions at baseline and follow-up. The response options are on a 5-point Likert scale that ranges from a value of 1 for strongly disagree to a value of 5 for strongly agree. Higher scores indicate stronger agreement with the statement and with the outcome.
Measured: 4-6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Jan 2024
- Study start6 Mar 2024
- Primary completion12 Dec 2024
- Study completion12 Dec 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pneumococcal Vaccine UptakeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants will be randomized 1:1 to receive either a web-based educational video about pneumococcal vaccination and a reminder email to be vaccinated or a reminder email alone.
- Masking
- Single blind
- Who is masked
- Investigator
- Enrolment
- 720 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Ottawa
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Giorgia Sulis, PhD, Principal investigator, School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06234683
- Sponsor's protocol ID
- CIRN Project SH-34
- Acronym
- PROPEL
- Status last verified
- Apr 2024
- First submitted
- 22 Jan 2024
- Last updated
- 30 Apr 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessing Barriers to Pneumococcal Vaccination to Increase Vaccine Uptake Among Older Adults: a Web-based Educational Intervention
- ClinicalTrials.gov ID
- NCT06234683
- Acronym / sponsor ID
- PROPEL / CIRN Project SH-34
- Conditions
- Pneumococcal Vaccine Uptake, Vaccination Willingness, Pneumococcal Vaccine Knowledge, Pneumococcal Vaccine Attitude
- Keywords
- pneumococcal vaccines, older adults, vaccine hesitancy, health education, web-based intervention
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 720 participants (actual)
- Lead sponsor
- University of OttawaUniversity, hospital or other
- Study start
- 6 Mar 2024 (actual)
- Primary completion
- 12 Dec 2024 (actual)
- Study completion
- 12 Dec 2024 (actual)
- First posted
- 31 Jan 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this trial is to compare the effect of a web-based educational video about pneumococcal vaccines and a reminder email to get vaccinated (intervention) with a reminder email alone (comparator) in adults aged 65 or older living in any Canadian province who reported not having received a pneumococcal vaccine.
The main questions this trial aims to answer are:
- does the educational intervention improve pneumococcal vaccine uptake,
- does the educational intervention improve willingness to be vaccinated,
- does the educational intervention improve knowledge of pneumococcal vaccination,
- and does the educational intervention improve attitudes towards pneumococcal vaccines/vaccination?
Eligible participants who provide electronic consent will:
- fill out a web-based baseline survey,
- receive access to the educational video (if assigned to the intervention group),
- receive an email reminder to be vaccinated (both groups),
- and fill in a web-based follow-up survey.
Detailed description
This research project is a web-based randomized controlled trial (RCT), targeting adults aged 65 years and older across all Canadian provinces. The primary objectives of this study are twofold. Firstly, it aims to assess the participants' knowledge, barriers, facilitators, and willingness to receive the pneumococcal vaccine at baseline. Secondly, it aims to evaluate the impact of a video-led educational intervention on pneumococcal vaccine literacy, willingness to be vaccinated, and the actual uptake of the vaccine. To this end, participants will be recruited through various online channels. Only individuals who have not received the pneumococcal vaccine will be considered eligible for inclusion. For the second objective, participants will be randomly assigned to either the intervention group (short video on pneumococcal vaccination) or the control group (reminder to receive a pneumococcal vaccine). Consenting participants will be required to complete two surveys: one at baseline and another approximately six months post-intervention. These surveys will provide valuable data for analyzing the effectiveness of the educational intervention in improving participants' knowledge, willingness to be vaccinated, and the actual uptake of the pneumococcal vaccine. Findings from this research will contribute to the understanding of factors influencing pneumococcal vaccine decision-making among older adults, ultimately informing strategies to enhance vaccine uptake and public health outcomes in this population.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (investigator)
- Number of arms
- 2
- Model description
- Participants will be randomized 1:1 to receive either a web-based educational video about pneumococcal vaccination and a reminder email to be vaccinated or a reminder email alone.
| Arm | Type | Receives |
|---|---|---|
| Web-based educational video on pneumococcal vaccination and reminder email to be vaccinated | Active comparator | Other: Web-based educational video on pneumococcal vaccination, Other: Reminder email to be vaccinated |
| Reminder email to be vaccinated | Placebo comparator | Other: Reminder email to be vaccinated |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Older adult
Key inclusion criteria (4 listed)
- adults aged ≥ 65 residing in any Canadian province,
- community dwelling (i.e., living outside of nursing homes),
- reporting not having received a pneumococcal vaccine, and
- being able to understand English and/or French.
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Web-based educational video on pneumococcal vaccinationParticipants will receive a link to view a short video on pneumococcal vaccination. | Other | Web-based educational video on pneumococcal vaccination and reminder email to be vaccinated |
| Reminder email to be vaccinatedParticipants will receive a reminder email to be vaccinated. | Other | Reminder email to be vaccinated, Web-based educational video on pneumococcal vaccination and reminder email to be vaccinated |
Primary outcome
Pneumococcal vaccine uptake measured using a web-based follow-up survey four to six months post-randomization
Time frame: 4-6 months
Participants will be asked at follow-up whether they received a pneumococcal vaccine since the last survey (yes/no/do not know).
3 secondary outcomes
Change in pneumococcal vaccination willingness, measured using web-based surveys (one at baseline and one four to six months post-randomization)
Time frame: 4-6 months
Change in pneumococcal vaccine knowledge measured using web-based surveys (one at baseline and one four to six months post-randomization)
Time frame: 4-6 months
Change in pneumococcal vaccine attitudes measured using web-based surveys (one at baseline and one four to six months post-randomization)
Time frame: 4-6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Apr 2025.
- Individual participant dataSharing planned: No
Related trials for Pneumococcal Vaccine Uptake
Enrolling by invitation
Randomized Controlled Trial Of Text Messages To Increase Pneumococcal Vaccination In Adults In Chile.
Pneumococcal Infections, Immunization Programs
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Giorgia Sulis, PhD principal investigator
School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Web-based educational video on pneumococcal vaccination and Reminder email to be vaccinated in people with Pneumococcal Vaccine Uptake and Vaccination Willingness, run by University of Ottawa at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pneumococcal vaccine uptake measured using a web-based follow-up survey four to six months post-randomization (time frame: 4-6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Apr 2025.